A Phase I Study of a Combination of 5-Azacyitidine Followed by Lenalidomide In High-Risk MDS or AML Patients with Chromosome 5 Abnormalities - Interim Results of the "AZALE" Trial.

作者:Platzbecker Uwe; Haase Detlef; Braulke Friederike; Bug Gesine; Goetze Katharina; Kuendgen Andrea; Roellig Christoph; Wermke Martin; Naumann Ralph; Bornhaeuser Martin; Giagounidis Aristoteles; Germing Ulrich; Hofmann Wolf Karsten; Ehninger Gerhard
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19